-
23 Oct 2026
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine months of 2026
by Roche News Feed
- Views 7
- More stats
-
22 Oct 2026
Roche presents new pivotal trial data across broad neuroimmunology portfolio at MSToronto2026
by Roche News Feed
- Views 79
- More stats
-
20 Oct 2026
Roche to present pivotal data at ESMO 2026, showcasing advances across its lung and breast cancer late-stage portfolio
by Roche News Feed
- Views 136
- More stats
-
17 Oct 2026
FDA approves Roche’s Enspryng, a first-in-class IL-6R inhibitor, as the first and only at-home subcutaneous treatment option for thyroid eye disease (TED)
by Roche News Feed
- Views 303
- More stats
-
11 Oct 2026
Roche presents new Phase III one-year data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
by Roche News Feed
- Views 321
- More stats
-
10 Oct 2026
FDA approves Roche’s Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer
by Roche News Feed
- Views 280
- More stats
-
01 Oct 2026
Roche presents new data at EURETINA, highlighting Vabysmo’s real-world effectiveness and safety across major retinal conditions
by Roche News Feed
- Views 350
- More stats
-
01 Oct 2026
Roche’s giredestrant combination significantly improved progression-free survival in ER-positive advanced breast cancer in phase III evERA data published in The New England Journal of Medicine
by Roche News Feed
- Views 421
- More stats
-
01 Oct 2026
Roche’s fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis
by Roche News Feed
- Views 390
- More stats
-
01 Oct 2026
Change in Roche’s Board of Directors
by Roche News Feed
- Views 294
- More stats
Latest News in Life Sciences
Read the latest news, announcements and press releases from life sciences and related disciplines, including news from biotechnology and pharmaceutical research and development. When you join Life Science Network, you can follow your favorite sources to get notified when content matching your interests is published.
You can post a news article here
Join Life Science Network
Join LSN to acces all jobs and fully benefit from the platform and its features.
News module
Are you interested in posting articles on Life Science Network?
Please continue reading here.
For more information about Life Science Network,
contact us at [email protected].
Advertisement